Location History:
- Fahrenzhausen, DE (2014)
- Starnberg, DE (2017)
Company Filing History:
2 out of 91 
1 out of 1 
1 out of 5 Years Active: 2014-2017
Title: Martin Hrabe De Angelis: Innovator in Diabetes Research
Introduction
Martin Hrabe De Angelis is a notable inventor based in Starnberg, Germany. He has made significant contributions to the field of diabetes research, particularly in identifying biomarkers for type 2 diabetes mellitus. His innovative work has the potential to impact the way diabetes is diagnosed and treated.
Latest Patents
Hrabe De Angelis holds a patent for a method of identifying a predisposition for developing type 2 diabetes mellitus. This method involves assessing specific metabolites in a sample obtained from a subject. The invention focuses on two groups of metabolites, where changes in their levels can indicate a predisposition to diabetes. Additionally, the patent outlines methods for identifying compounds that can prevent diabetes and selecting appropriate therapies.
Career Highlights
Throughout his career, Martin Hrabe De Angelis has worked with prominent research institutions. He has been associated with the Helmholtz Zentrum München, which is known for its research in health and environmental sciences. He has also contributed to the Deutsche Diabetes-Forschungsgesellschaft, which is the German Diabetes Center in Düsseldorf. His work in these organizations has furthered the understanding of diabetes and its prevention.
Collaborations
Hrabe De Angelis has collaborated with notable colleagues in the field, including Wolfgang Rathmann and Christian Herder. These collaborations have enhanced the research efforts in diabetes and have led to significant advancements in the understanding of the disease.
Conclusion
Martin Hrabe De Angelis is a key figure in diabetes research, with a focus on innovative methods for identifying and preventing type 2 diabetes mellitus. His contributions through patents and collaborations continue to shape the future of diabetes care and research.